Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | 0.00% |
|
+4.48% | -48.15% |
Jun. 30 | Enlivex Therapeutics Ltd.'s Equity Buyback announced on August 30, 2023 has expired. | CI |
Jun. 24 | Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ENLV Stock
- News Enlivex Therapeutics Ltd.
- Official Publications